Members from the department of bioengineering tabled an event at the Office of the Vice President for Research and Innovation's week of research and innovation, to showcase bioengineering research for undergraduate students.
Knight Campus Building 2 opened to the public on Monday, March 30. Building 2 is part of the second phase of Knight Campus development, a 185,000-square-foot, multi-story bioengineering and applied science research facility.
Get to know one of our newest hires! Nanomaterial immunoengineer David Peeler joined the department in January 2026, bringing research with the potential to improve antimicrobials, immunotherapies and vaccines.
Set to open in March of 2026, Building 2 of the Phil and Penny Knight Campus for Accelerating Scientific Impact is a dedicated space for world-class research and hands-on training.
Therapeutic ultrasound engineer Sara Keller and nanomaterial immunoengineer David Peeler will join the department in January 2026, bringing research with the potential to improve antimicrobials, immunotherapies and vaccines.
The Peeler Lab
Founded in 2026, the Peeler Lab is a biomaterial research group within the University of Oregon's Phil and Penny Knight Campus for Accelerating Scientific Impact. Based in the Department of Bioengineering in Eugene, Oregon, the Peeler lab develops biomaterials for immunomodulation, drug delivery, and genetic engineering.
